UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016909 |
|---|---|
| Receipt number | R000019607 |
| Scientific Title | Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer (JCOG1410-A, JUPITER study) |
| Date of disclosure of the study information | 2015/03/25 |
| Last modified on | 2015/03/25 11:34:12 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer
(JCOG1410-A, JUPITER study)
Acronym
Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer
(JCOG1410-A, JUPITER study)
Scientific Title
Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer
(JCOG1410-A, JUPITER study)
Scientific Title:Acronym
Japanese observational study to evaluate the accuracy of preoperative imaging diagnosis for lateral pelvic lymph node metastasis in rectal cancer
(JCOG1410-A, JUPITER study)
Region
| Japan |
Condition
Condition
Rectal cancer with rectal resection and lateral pelvic lymph node dissection
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Herein, we examine the relationship between preoperative factors (including imaging findings [CT/MRI], patient factors, and tumor factors) and the presence of pathological lateral lymph nodes metastasis in patients with rectal cancer undergoing rectal resection with lateral pelvic lymph node dissection. From these results, we identify the predicting factors for positive lateral pelvic lymph node metastasis, and determine the criteria of lateral pelvic lymph node positivity in the preoperative diagnosis.
Basic objectives2
Others
Basic objectives -Others
Observational Study
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
False discovery rate (C/C+D)* regarding the diagnosis of lateral pelvic lymph node metastasis. (*: see below colum)
Key secondary outcomes
<1>False omission rate (B/A+B), positive predictive value (D/C+D), negative predictive value (A/A+B), sensitivity (D/B+D), and specificity (A/A+C) regarding the diagnosis of lateral pelvic lymph node metastasis.
<2> False discovery rate (C/C+D), false omission rate (B/A+B), positive predictive value (D/C+D), negative predictive value (A/A+B), sensitivity (D/B+D), and specificity (A/A+C) regarding the diagnosis of lateral pelvic lymph node metastasis when adjusted for one or more patient and tumor factors (including gender, histological tumor type, invasion depth, lymph node metastasis in the mesorectum, and distance from the lower edge of the tumor to the anal verge, which were all determined as factors associated with lateral pelvic lymph node metastasis) and the size of the minor axis of the lateral pelvic lymph node in the imaging studies.
<3> The differences between the central review result and the imaging diagnosis of each institution.
A=preoperatively negative & pathologically negative
B= preoperatively negative & pathologically positive
C= preoperatively positive & pathologically negative
D= preoperatively positive& pathologically positive
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Adenocarcinoma or adenosquamous carcinoma is pathologically diagnosed by preoperative biopsy.
2) Pelvic enhanced CT and MRI are performed for preoperative imaging (CT data of 1 mm/1.25 mm-thickness and 5 mm-thickness slices, and MRI data of 3 mm-thickness slices are required).
3) Satisfying either of the following criteria: the main tumor part is located either in the lower rectum or anal canal, or the lower edge of the tumor is located in the lower rectum.
<1> The tumor invasion depth is deeper than T2.
<2> Lateral pelvic lymph node metastasis is suspected by preoperative imaging.
<3> Lymph node metastasis in the mesorectum is suspected by preoperative imaging.
4) Chemotherapy and radiotherapy to the rectal cancer is not performed before the operation, and lateral pelvic lymph node dissection is planned simultaneously with rectal resection.
5) There is no past history of operation, chemotherapy, and radiotherapy to intrapelvic tumors (rectal cancer, gynecologic cancer, urologic cancer, etc.).
6) There is no finding of distant organ metastasis, distant lymph node metastasis, and peritoneal dissemination in the preoperative imaging studies (except for cStage IV).
Key exclusion criteria
No exclusion criteria
Target sample size
550
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yukihide Kanemitsu |
Organization
National Cancer Center Hospital
Division name
Division of medical oncology
Zip code
Address
5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan 104-0045
TEL
03-3542-2511
ykanemit@ncc.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Satoshi Ikeda |
Organization
JCOG1410-A Coordinating Office
Division name
Department of gastroenterology, Hiroshima Prefectural Hospital
Zip code
Address
5-54, Uzinakannda 1-Chome, Minami-Ku, Hiroshima 734-8530
TEL
082-254-1818
Homepage URL
http://www.jcog.jp/
JCOG_sir@ml.jcog.jp
Sponsor or person
Institute
Japan Clinical Oncology Group (JCOG)
Institute
Department
Personal name
Funding Source
Organization
Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
札幌厚生病院（北海道）
岩手医科大学（岩手県）
宮城県立がんセンター（宮城県）
山形県立中央病院（山形県）
栃木県立がんセンター（栃木県）
防衛医科大学校（埼玉県）
埼玉県立がんセンター（埼玉県）
自治医科大学附属さいたま医療センター（埼玉県）
埼玉医科大学国際医療センター（埼玉県）
国立がん研究センター東病院（千葉県）
千葉県がんセンター（千葉県）
順天堂大学医学部附属浦安病院（千葉県）
国立がん研究センター中央病院（東京都）
杏林大学医学部（東京都）
東京医科大学病院（東京都）
がん・感染症センター都立駒込病院（東京都）
慶應義塾大学病院（東京都）
東京医科歯科大学（東京都）
東邦大学医療センター大橋病院（東京都）
北里大学東病院（神奈川県）
神奈川県立がんセンター（神奈川県）
横浜市立市民病院（神奈川県）
北里大学医学部（神奈川県）
昭和大学横浜市北部病院（神奈川県）
横浜市立大学附属市民総合医療センター（神奈川県）
済生会横浜市南部病院（神奈川県）
新潟県立がんセンター新潟病院（新潟県）
新潟県厚生連長岡中央綜合病院（新潟県）
石川県立中央病院（石川県）
長野市民病院（長野県）
岐阜大学医学部（岐阜県）
静岡県立静岡がんセンター（静岡県）
愛知県がんセンター中央病院（愛知県）
藤田保健衛生大学（愛知県）
大阪大学医学部（大阪府）
大阪府立病院機構大阪府立成人病センター（大阪府）
国立病院機構大阪医療センター（大阪府）
大阪府立病院機構大阪府立急性期・総合医療センター（大阪府）
大阪医科大学（大阪府）
市立堺病院（大阪府）
箕面市立病院（大阪府）
市立吹田市民病院（大阪府）
関西労災病院（兵庫県）
兵庫医科大学（兵庫県）
医療法人薫風会佐野病院（兵庫県）
岡山済生会総合病院（岡山県）
広島市立広島市民病院（広島県）
県立広島病院（広島県）
広島市立安佐市民病院（広島県）
国立病院機構四国がんセンター（愛媛県）
高知医療センター（高知県）
久留米大学医学部（福岡県）
熊本大学医学部（熊本県）
大分大学医学部附属病院（大分県）
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 03 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2015 | Year | 02 | Month | 12 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 03 | Month | 25 | Day |
Last follow-up date
| 2016 | Year | 09 | Month | 25 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Herein, we examine the relationship between preoperative factors (including imaging findings [CT/MRI], patient factors, and tumor factors) and the presence of pathological lateral lymph nodes metastasis in patients with rectal cancer undergoing rectal resection with lateral pelvic lymph node dissection. From these results, we identify the predicting factors for positive lateral pelvic lymph node metastasis, and determine the criteria of lateral pelvic lymph node positivity in the preoperative diagnosis.
Management information
Registered date
| 2015 | Year | 03 | Month | 25 | Day |
Last modified on
| 2015 | Year | 03 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019607
